Search Count: 9
 |
Inactive Mu-Opioid Receptor With Nb6M, Nabfab, And Isoquinuclidine Compound #33
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: MEMBRANE PROTEIN |
 |
Inactive Mu-Opioid Receptor With Nb6M, Nabfab, And Isoquinuclidine Compound #020_E1
Organism: Homo sapiens, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: MEMBRANE PROTEIN Ligands: A1BNM |
 |
Locally-Refined Inactive Mu-Opioid Receptor With Nb6M, Nabfab, And Isoquinuclidine Compound #020_E1
Organism: Homo sapiens
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: MEMBRANE PROTEIN Ligands: A1BNM |
 |
Inactive Kappa-Opioid Receptor With Nb6M, Nabfab, And Isoquinuclidine Compound #020_E1
Organism: Mus musculus, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: MEMBRANE PROTEIN Ligands: A1BNM |
 |
Locally-Refined Inactive Kappa-Opioid Receptor With Nb6M, Nabfab, And Isoquinuclidine Compound #020_E1
Organism: Mus musculus
Method: ELECTRON MICROSCOPY Release Date: 2025-02-12 Classification: MEMBRANE PROTEIN Ligands: A1BNM |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2024-10-23 Classification: HYDROLASE Ligands: A1AU5 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.66 Å Release Date: 2024-06-19 Classification: HYDROLASE Ligands: A1AUT |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-06-19 Classification: HYDROLASE Ligands: A1AU0 |
 |
Organism: Escherichia coli
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2024-06-19 Classification: HYDROLASE Ligands: A1AU1 |